Top Big Cap Positive News Movers Premarket:  SNOW: +24% Earnings NTSK: +11% Earnings HCM: +10% Licensing Agreement with GSK for KRAS-EGFR-Antibody Conjugate Cancer Therapy SMMT: +6% Ivonescimab Monotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in HARMONi-2 Study  FIVE: +4% Earnings MIR: +2% Initiated BUY @ Jefferies 03-SEP-2026 08:10 AM ET